Subject(s)
Coccidioides/isolation & purification , Coccidioidomycosis/microbiology , Lung Transplantation/adverse effects , Tissue Donors , Travel , Antibodies, Fungal/blood , Antifungal Agents/therapeutic use , Arizona , Coccidioides/immunology , Coccidioidomycosis/diagnosis , Coccidioidomycosis/drug therapy , Coccidioidomycosis/transmission , France , Humans , Idiopathic Pulmonary Fibrosis/surgery , Immunosuppressive Agents/therapeutic use , Itraconazole/therapeutic use , Male , Middle Aged , Treatment OutcomeABSTRACT
Parasitic diseases are cosmopolitan and may affect all the world population. They kill several million people every year. The migrations and tourism make that even tropical diseases can be frequently met outside their geographical distribution area. Except the arthropod-borne infections, the great majority of these diseases are in relation with the faecal contamination of soil, the general level of hygiene and the food practices. Malaria remains the first world parasitic disease in term of mortality. The strong fall of the amoebic endemicity is due only to the improvement of the methods of molecular diagnosis. The socio-political and climatic upheavals may result in a creeping extension of the geographical limits of many parasites.
Subject(s)
Helminthiasis/epidemiology , Protozoan Infections/epidemiology , Global Health , HumansABSTRACT
The efficacy of praziquantel started during the incubation period of schistosomiasis has not been studied. Eighteen tourists were infected by Schistosoma haematobium during summer 2003 after bathing once in the same cascade in Mali. We observed the efficacy of praziquantel given at different phases. They received praziquantel at the first consultation, from Days 10 to 15 after exposure in eight asymptomatic patients (Group 1), from Days 28 to 40 in 4 asymptomatic patients (Group 2), and from Days 20 to 39 in 6 patients with acute schistosomiasis (Group 3). All Group 1 patients developed acute schistosomiasis, compared with none of the Group 2 patients (P < 0.004). Among the 10 patients treated during the acute phase, clinical status deteriorated in four cases. Seventeen of the 18 patients developed chronic schistosomiasis. Early praziquantel treatment was thus less effective than later treatment in preventing acute schistosomiasis, while neither treatment effectively prevented chronic schistosomiasis.